187: What everyone got wrong about Dr. Rachel Pope's perimenopause hormone therapy study episode artwork

EPISODE · Nov 27, 2025 · 37 MIN

187: What everyone got wrong about Dr. Rachel Pope's perimenopause hormone therapy study

from The Hotflash inc podcast · host Hotflash inc

Send a textIn this episode of the Hotflash Inc Podcast, host and journalist Ann Marie McQueen is joined by Dr. Rachel Pope, an OB-GYN and certified menopause practitioner at the Institute University Hospitals Cleveland, with an appointment in the Department of Reproductive Biology. Dr. Pope is also a public health researcher, currently working to clarify gaps in hormone therapy research that impact real women every day.Dr. Pope’s recent study set social media on fire, with claims that hormone therapy in perimenopause reduces breast cancer, stroke, and heart attack risk by 60%. But is that actually what the data said? In this episode, Dr. Pope gives a clear, honest account of what her study really found – and what it didn’t. She speaks about the confusion that followed, why nuance matters, her belief in the power of hormone therapy and how to move forward in the menopause conversation with more care, accuracy and integrity.This is a must-listen for anyone navigating perimenopause, hormone therapy decisions or working in the midlife health space.Sponsor ShoutoutThank you to our sponsor, Timeline Nutrition – makers of Mitopure™, the first clinically tested Urolithin A supplement that supports cellular energy and muscle strength. Visit www.timeline.com and use the code HOTFLASH for 20% off your first order.Thank you to Bonafide, a gold sponsor at the Hotflash Inc Summit. To learn more, visit hellobonafide.com and be sure to use code SUMMIT20 to receive 20% off the first month of any Bonafide subscription product.HighlightsThe truth behind the viral claim that hormone therapy “reduces risk by 60%.”Why misinterpretation of data spreads so fast — especially on social media.What the research actually says about breast cancer, stroke, and heart attack.The gaps in current evidence, especially around compounded hormones and long-term outcomes.How healthy-user bias and retrospective databases can distort study results.Why individualized care matters — and why hormone therapy isn’t universally preventative.GUEST LINKSUniversity Hospitals Cleveland Medical CenterInstagram: @drrpopeX: @drrpope Join the Hotflash inc perimenoposse: Web: hotflashinc.comNewsletter: Hotflash inc. on SubstackTikTok: @hotflashincInstagram: @hotflashincX: @hotflashinc Episode website: Hotflashinc Listen on: Apple Podcasts | Spotify | Google Podcasts | YouTube | Substack See hotflashinc.com/privacy-policy for privacy information

Send a textIn this episode of the Hotflash Inc Podcast, host and journalist Ann Marie McQueen is joined by Dr. Rachel Pope, an OB-GYN and certified menopause practitioner at the Institute University Hospitals Cleveland, with an appointment in the Department of Reproductive Biology. Dr. Pope is also a public health researcher, currently working to clarify gaps in hormone therapy research that impact real women every day.Dr. Pope’s recent study set social media on fire, with claims that hormone therapy in perimenopause reduces breast cancer, stroke, and heart attack risk by 60%. But is that actually what the data said? In this episode, Dr. Pope gives a clear, honest account of what her study really found – and what it didn’t. She speaks about the confusion that followed, why nuance matters, her belief in the power of hormone therapy and how to move forward in the menopause conversation with more care, accuracy and integrity.This is a must-listen for anyone navigating perimenopause, hormone therapy decisions or working in the midlife health space.Sponsor ShoutoutThank you to our sponsor, Timeline Nutrition – makers of Mitopure™, the first clinically tested Urolithin A supplement that supports cellular energy and muscle strength. Visit www.timeline.com and use the code HOTFLASH for 20% off your first order.Thank you to Bonafide, a gold sponsor at the Hotflash Inc Summit. To learn more, visit hellobonafide.com and be sure to use code SUMMIT20 to receive 20% off the first month of any Bonafide subscription product.HighlightsThe truth behind the viral claim that hormone therapy “reduces risk by 60%.”Why misinterpretation of data spreads so fast — especially on social media.What the research actually says about breast cancer, stroke, and heart attack.The gaps in current evidence, especially around compounded hormones and long-term outcomes.How healthy-user bias and retrospective databases can distort study results.Why individualized care matters — and why hormone therapy isn’t universally preventative.GUEST LINKSUniversity Hospitals Cleveland Medical CenterInstagram: @drrpopeX: @drrpope Join the Hotflash inc perimenoposse: Web: hotflashinc.comNewsletter: Hotflash inc. on SubstackTikTok: @hotflashincInstagram: @hotflashincX: @hotflashinc Episode website: Hotflashinc Listen on: Apple Podcasts | Spotify | Google Podcasts | YouTube | Substack See hotflashinc.com/privacy-policy for privacy information

NOW PLAYING

187: What everyone got wrong about Dr. Rachel Pope's perimenopause hormone therapy study

0:00 37:35

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Hotflash inc podcast?

This episode is 37 minutes long.

When was this The Hotflash inc podcast episode published?

This episode was published on November 27, 2025.

What is this episode about?

Send a textIn this episode of the Hotflash Inc Podcast, host and journalist Ann Marie McQueen is joined by Dr. Rachel Pope, an OB-GYN and certified menopause practitioner at the Institute University Hospitals Cleveland, with an appointment in the...

Can I download this The Hotflash inc podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!